1 | 23438607 | Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. | Indian Heart J | 2013 Jan-Feb |
1 |
2 | 25776937 | MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in cardiomyocytes. | Mol Med Rep | 2015 Jul |
1 |
3 | 26010876 | MicroRNAs Regulate Cellular ATP Levels by Targeting Mitochondrial Energy Metabolism Genes during C2C12 Myoblast Differentiation. | PLoS One | 2015 |
3 |
4 | 26562412 | Expression Patterns of miRNA-423-5p in the Serum and Pericardial Fluid in Patients Undergoing Cardiac Surgery. | PLoS One | 2015 |
1 |
5 | 27220832 | MicroRNA‑423‑5p mediates H2O2‑induced apoptosis in cardiomyocytes through O‑GlcNAc transferase. | Mol Med Rep | 2016 Jul |
9 |
6 | 28577875 | Circulating miR-150, miR-192, miR-200b, and miR-423-3p as Non-invasive Biomarkers of Chronic Allograft Dysfunction. | Arch Med Res | 2017 Jan |
1 |
7 | 30116373 | MicroRNA-423-5p inhibits colon cancer growth by promoting caspase-dependent apoptosis. | Exp Ther Med | 2018 Aug |
1 |
8 | 30245133 | miR-423-5p suppresses high-glucose-induced podocyte injury by targeting Nox4. | Biochem Biophys Res Commun | 2018 Oct 28 |
4 |
9 | 30344696 | MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells. | Exp Ther Med | 2018 Nov |
3 |
10 | 30472788 | Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shock. | ESC Heart Fail | 2019 Feb |
1 |
11 | 30865275 | Dysregulated miR-142, -33b and -423 in granulosa cells target TGFBR1 and SMAD7: a possible role in polycystic ovary syndrome. | Mol Hum Reprod | 2019 Oct 28 |
1 |
12 | 31071929 | Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium. | Int J Mol Sci | 2019 May 8 |
1 |
13 | 31074036 | MiR-423-5p inhibition alleviates cardiomyocyte apoptosis and mitochondrial dysfunction caused by hypoxia/reoxygenation through activation of the wnt/β-catenin signaling pathway via targeting MYBL2. | J Cell Physiol | 2019 Dec |
3 |
14 | 31424364 | Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner. | Curr Drug Metab | 2019 |
1 |
15 | 31455213 | NFE2/miR-423-5p/TFF1 axis regulates high glucose-induced apoptosis in retinal pigment epithelial cells. | BMC Mol Cell Biol | 2019 Aug 27 |
2 |
16 | 32862605 | Effects of miR-432 and miR-548c-3p on the proliferation and invasion of osteosarcoma cells. | J BUON | 2020 May-Jun |
1 |
17 | 32993185 | Acute Kidney Injury in Septic Patients Treated by Selected Nephrotoxic Antibiotic Agents-Pathophysiology and Biomarkers-A Review. | Int J Mol Sci | 2020 Sep 26 |
2 |
18 | 33144675 | Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway. | Exp Mol Med | 2020 Nov |
1 |
19 | 33464446 | Silencing of UCA1 Protects Against MPP<sup>+</sup>-Induced Cytotoxicity in SK-N-SH Cells via Modulating KCTD20 Expression by Sponging miR-423-5p. | Neurochem Res | 2021 Apr |
2 |
20 | 33493140 | Cross-platform genomic identification and clinical validation of breast cancer diagnostic biomarkers. | Aging (Albany NY) | 2021 Jan 20 |
1 |
21 | 34532814 | Long non-cording RNA XIST promoted cell proliferation and suppressed apoptosis by miR-423-5p/HMGA2 axis in diabetic nephropathy. | Mol Cell Biochem | 2021 Dec |
1 |
22 | 34955881 | Plasma Exosomal Mir-423-5p Is Involved in the Occurrence and Development of Bicuspid Aortopathy <i>via</i> TGF-β/SMAD2 Pathway. | Front Physiol | 2021 |
1 |
23 | 35015607 | The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway. | Bioengineered | 2022 Feb |
1 |
24 | 35348192 | Circulating microRNA‑423 attenuates the phosphorylation of calcium handling proteins in atrial fibrillation. | Mol Med Rep | 2022 May |
3 |